[
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2,
    "95% CI (%)": "0.0 - 4.3",
    "Sample Size": 275,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "8.6 - 14.1",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.1,
    "95% CI (%)": "2.4 - 7.8",
    "Sample Size": 372,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.5,
    "95% CI (%)": "21.0 - 30.0",
    "Sample Size": 564,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "8.0 - 14.4",
    "Sample Size": 531,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 23.9,
    "95% CI (%)": "19.9 - 27.9",
    "Sample Size": 673,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.2,
    "95% CI (%)": "23.0 - 37.4",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.1,
    "95% CI (%)": "17.4 - 26.9",
    "Sample Size": 425,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "2.4 - 11.0",
    "Sample Size": 125,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 21.8,
    "95% CI (%)": "14.8 - 28.7",
    "Sample Size": 203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.5 - 2.7",
    "Sample Size": 308,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 26.2,
    "95% CI (%)": "21.8 - 30.6",
    "Sample Size": 641,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.6,
    "95% CI (%)": "11.3 - 23.9",
    "Sample Size": 200,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "10.5 - 17.7",
    "Sample Size": 506,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "0.8 - 12.2",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.2,
    "95% CI (%)": "18.2 - 32.1",
    "Sample Size": 274,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "6.8 - 28.3",
    "Sample Size": 68,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.3,
    "95% CI (%)": "12.5 - 18.2",
    "Sample Size": 867,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.9,
    "95% CI (%)": "8.8 - 29.0",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 12.0",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "10.4 - 17.9",
    "Sample Size": 412,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "9.8 - 15.1",
    "Sample Size": 667,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "13.1 - 19.0",
    "Sample Size": 827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "8.8 - 19.4",
    "Sample Size": 218,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "16.0 - 23.7",
    "Sample Size": 649,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "0.4 - 11.6",
    "Sample Size": 60,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "3.6 - 12.2",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.9,
    "95% CI (%)": "4.7 - 41.1",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.8,
    "95% CI (%)": "9.6 - 20.1",
    "Sample Size": 263,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.2 - 21.0",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "14.7 - 20.9",
    "Sample Size": 872,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.9,
    "95% CI (%)": "14.3 - 23.4",
    "Sample Size": 417,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17,
    "95% CI (%)": "13.9 - 20.1",
    "Sample Size": 809,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "0.0 - 13.3",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.5 - 19.2",
    "Sample Size": 919,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.1,
    "95% CI (%)": "4.1 - 16.2",
    "Sample Size": 108,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.7,
    "95% CI (%)": "11.6 - 21.8",
    "Sample Size": 344,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 50.7,
    "95% CI (%)": "40.5 - 61.0",
    "Sample Size": 179,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "13.6 - 19.3",
    "Sample Size": 920,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 48,
    "95% CI (%)": "40.9 - 55.1",
    "Sample Size": 348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.6 - 4.5",
    "Sample Size": 607,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "0.0 - 13.5",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.0 - 1.7",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.5 - 19.3",
    "Sample Size": 916,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.5,
    "95% CI (%)": "16.8 - 34.3",
    "Sample Size": 178,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.8,
    "95% CI (%)": "0.0 - 14.2",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.2,
    "95% CI (%)": "13.3 - 19.0",
    "Sample Size": 908,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "3.6 - 9.2",
    "Sample Size": 305,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.6,
    "95% CI (%)": "24.6 - 36.5",
    "Sample Size": 399,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "13.2 - 18.9",
    "Sample Size": 930,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "0.0 - 17.5",
    "Sample Size": 30,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.4,
    "95% CI (%)": "12.7 - 18.1",
    "Sample Size": 934,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.2,
    "95% CI (%)": "13.4 - 19.0",
    "Sample Size": 921,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "13.2 - 18.8",
    "Sample Size": 927,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "13.3 - 19.0",
    "Sample Size": 925,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "1.3 - 22.0",
    "Sample Size": 55,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "3.6 - 12.2",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 12.0",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.9,
    "95% CI (%)": "13.9 - 19.9",
    "Sample Size": 856,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "16.0 - 23.7",
    "Sample Size": 649,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.9,
    "95% CI (%)": "6.3 - 27.5",
    "Sample Size": 63,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.6,
    "95% CI (%)": "13.1 - 26.2",
    "Sample Size": 254,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.7,
    "95% CI (%)": "13.0 - 18.4",
    "Sample Size": 958,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "6.8 - 20.0",
    "Sample Size": 153,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.9 - 20.3",
    "Sample Size": 738,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.4,
    "95% CI (%)": "0.0 - 8.8",
    "Sample Size": 41,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 4.4",
    "Sample Size": 51,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 27.3,
    "95% CI (%)": "12.0 - 42.5",
    "Sample Size": 53,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 32.6,
    "95% CI (%)": "25.7 - 39.5",
    "Sample Size": 314,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.5,
    "95% CI (%)": "3.3 - 11.6",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.2 - 2.2",
    "Sample Size": 235,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.4 - 14.1",
    "Sample Size": 329,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 762,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 19.1,
    "95% CI (%)": "10.1 - 28.1",
    "Sample Size": 126,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 9.8,
    "95% CI (%)": "4.7 - 14.9",
    "Sample Size": 258,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.1",
    "Sample Size": 118,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "0.0 - 17.4",
    "Sample Size": 47,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "1.6 - 10.7",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "1.4 - 7.3",
    "Sample Size": 191,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "7.1 - 21.1",
    "Sample Size": 159,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "3.1 - 7.3",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.3 - 5.5",
    "Sample Size": 651,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "0.5 - 11.5",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.9 - 6.6",
    "Sample Size": 708,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "4.7 - 10.7",
    "Sample Size": 463,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 3.7",
    "Sample Size": 260,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "0.4 - 8.4",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 8.3,
    "95% CI (%)": "0.0 - 17.7",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 747,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.7,
    "95% CI (%)": "3.1 - 8.4",
    "Sample Size": 381,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "3.9 - 11.7",
    "Sample Size": 213,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.4",
    "Sample Size": 289,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.0 - 4.8",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.4",
    "Sample Size": 751,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "1.3 - 9.7",
    "Sample Size": 210,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 762,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 207,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.2 - 4.8",
    "Sample Size": 403,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant, trying to get pregnant, or breastfeeding",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 3.3",
    "Sample Size": 107,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.5,
    "95% CI (%)": "1.7 - 5.3",
    "Sample Size": 557,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.7 - 6.3",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.5,
    "95% CI (%)": "1.7 - 5.3",
    "Sample Size": 557,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "1.3 - 9.7",
    "Sample Size": 210,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 764,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "2.8 - 6.1",
    "Sample Size": 774,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "0.0 - 17.4",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.0 - 3.0",
    "Sample Size": 39,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 747,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 33.7,
    "95% CI (%)": "21.0 - 46.5",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "2.6 - 6.0",
    "Sample Size": 687,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.2 - 2.2",
    "Sample Size": 235,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.4,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.7 - 6.3",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "0.0 - 9.4",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.7,
    "95% CI (%)": "3.1 - 8.4",
    "Sample Size": 381,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "4.0 - 8.7",
    "Sample Size": 511,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.4 - 7.0",
    "Sample Size": 358,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5,
    "95% CI (%)": "2.2 - 7.9",
    "Sample Size": 326,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.0 - 4.8",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "0.0 - 8.4",
    "Sample Size": 123,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "3.1 - 7.3",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "0.0 - 8.4",
    "Sample Size": 123,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.2,
    "95% CI (%)": "1.8 - 6.6",
    "Sample Size": 416,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "2.5 - 6.1",
    "Sample Size": 671,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.9 - 6.6",
    "Sample Size": 708,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "7.1 - 21.1",
    "Sample Size": 159,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5,
    "95% CI (%)": "2.2 - 7.9",
    "Sample Size": 326,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "3.1 - 7.3",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "1.0 - 3.5",
    "Sample Size": 611,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 758,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "0.0 - 8.4",
    "Sample Size": 123,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "3.4 - 13.0",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "1.4 - 7.3",
    "Sample Size": 191,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "0.0 - 17.4",
    "Sample Size": 47,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "4.7 - 10.7",
    "Sample Size": 463,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant, trying to get pregnant, or breastfeeding",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 3.3",
    "Sample Size": 107,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.0 - 4.8",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "7.1 - 21.1",
    "Sample Size": 159,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.1",
    "Sample Size": 118,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 758,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.4 - 2.6",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "0.0 - 17.4",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "1.8 - 10.5",
    "Sample Size": 294,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 11.2",
    "Sample Size": 122,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.4 - 5.4",
    "Sample Size": 586,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.2 - 2.2",
    "Sample Size": 235,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "1.4 - 7.3",
    "Sample Size": 191,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "2.5 - 6.1",
    "Sample Size": 671,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.7 - 6.3",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.3,
    "95% CI (%)": "0.0 - 3.2",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.4",
    "Sample Size": 289,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.3 - 5.5",
    "Sample Size": 651,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "0.0 - 9.4",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.4 - 7.0",
    "Sample Size": 358,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "0.0 - 8.4",
    "Sample Size": 123,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "3.0 - 6.6",
    "Sample Size": 715,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.4,
    "95% CI (%)": "1.3 - 5.6",
    "Sample Size": 387,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "7.1 - 21.1",
    "Sample Size": 159,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.4",
    "Sample Size": 289,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 207,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.7,
    "95% CI (%)": "1.0 - 10.5",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 11.2",
    "Sample Size": 122,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.4 - 5.4",
    "Sample Size": 586,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5,
    "95% CI (%)": "0.0 - 10.7",
    "Sample Size": 87,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.4 - 14.1",
    "Sample Size": 329,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "1.0 - 7.2",
    "Sample Size": 205,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 8.3,
    "95% CI (%)": "0.0 - 17.7",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "3.0 - 6.6",
    "Sample Size": 715,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.4,
    "95% CI (%)": "1.3 - 5.6",
    "Sample Size": 387,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 3.7",
    "Sample Size": 260,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "0.4 - 8.4",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "4.7 - 10.7",
    "Sample Size": 463,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.3,
    "95% CI (%)": "3.9 - 8.8",
    "Sample Size": 560,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "0.0 - 9.4",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 11.2",
    "Sample Size": 122,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.4",
    "Sample Size": 751,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.1",
    "Sample Size": 118,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.0 - 3.0",
    "Sample Size": 39,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.4",
    "Sample Size": 751,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "0.0 - 17.4",
    "Sample Size": 47,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 19.1,
    "95% CI (%)": "10.1 - 28.1",
    "Sample Size": 126,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "0.0 - 8.4",
    "Sample Size": 123,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.2,
    "95% CI (%)": "1.8 - 6.6",
    "Sample Size": 416,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5,
    "95% CI (%)": "2.2 - 7.9",
    "Sample Size": 326,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 8.3,
    "95% CI (%)": "0.0 - 17.7",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "0.5 - 11.5",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "3.0 - 6.6",
    "Sample Size": 715,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "0.5 - 11.5",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "0.4 - 8.4",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.4,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.2 - 4.8",
    "Sample Size": 403,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.2,
    "95% CI (%)": "1.8 - 6.6",
    "Sample Size": 416,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 747,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "3.9 - 11.7",
    "Sample Size": 213,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5,
    "95% CI (%)": "0.0 - 10.7",
    "Sample Size": 87,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 33.7,
    "95% CI (%)": "21.0 - 46.5",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 9.8,
    "95% CI (%)": "4.7 - 14.9",
    "Sample Size": 258,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.4,
    "95% CI (%)": "1.3 - 5.6",
    "Sample Size": 387,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.7,
    "95% CI (%)": "1.0 - 10.5",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "1.0 - 7.2",
    "Sample Size": 205,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 747,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.7,
    "95% CI (%)": "4.7 - 10.7",
    "Sample Size": 463,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5,
    "95% CI (%)": "0.0 - 10.7",
    "Sample Size": 87,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 19.1,
    "95% CI (%)": "10.1 - 28.1",
    "Sample Size": 126,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 764,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.4 - 5.4",
    "Sample Size": 586,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5,
    "95% CI (%)": "0.0 - 10.7",
    "Sample Size": 87,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.2,
    "95% CI (%)": "0.2 - 2.2",
    "Sample Size": 235,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 762,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "2.6 - 6.0",
    "Sample Size": 687,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "2.8 - 6.1",
    "Sample Size": 774,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.4 - 14.1",
    "Sample Size": 329,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "1.6 - 10.7",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "1.3 - 9.7",
    "Sample Size": 210,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "0.0 - 17.4",
    "Sample Size": 47,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 9.8,
    "95% CI (%)": "4.7 - 14.9",
    "Sample Size": 258,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 747,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 33.7,
    "95% CI (%)": "21.0 - 46.5",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 764,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 9.7,
    "95% CI (%)": "5.4 - 14.1",
    "Sample Size": 329,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 762,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 758,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "2.6 - 6.0",
    "Sample Size": 687,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "2.8 - 6.1",
    "Sample Size": 774,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.0 - 3.0",
    "Sample Size": 39,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "1.3 - 9.7",
    "Sample Size": 210,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "1.6 - 10.7",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 9.8,
    "95% CI (%)": "4.7 - 14.9",
    "Sample Size": 258,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 33.7,
    "95% CI (%)": "21.0 - 46.5",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "0.0 - 17.4",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 747,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.4 - 2.6",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "1.8 - 10.5",
    "Sample Size": 294,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.9 - 6.6",
    "Sample Size": 708,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 747,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.4 - 7.0",
    "Sample Size": 358,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "1.0 - 7.2",
    "Sample Size": 205,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.3 - 5.5",
    "Sample Size": 651,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "3.9 - 11.7",
    "Sample Size": 213,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "3.1 - 7.3",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.1,
    "95% CI (%)": "0.0 - 9.4",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.2 - 4.8",
    "Sample Size": 403,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "0.4 - 8.4",
    "Sample Size": 88,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.4,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 3.7",
    "Sample Size": 260,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant, trying to get pregnant, or breastfeeding",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 3.3",
    "Sample Size": 107,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.7,
    "95% CI (%)": "1.0 - 10.5",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.5,
    "95% CI (%)": "1.7 - 5.3",
    "Sample Size": 557,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "1.0 - 3.5",
    "Sample Size": 611,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "4.0 - 8.7",
    "Sample Size": 511,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "3.4 - 13.0",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.4,
    "95% CI (%)": "1.3 - 5.6",
    "Sample Size": 387,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 207,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.1,
    "95% CI (%)": "1.0 - 7.2",
    "Sample Size": 205,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 8.3,
    "95% CI (%)": "0.0 - 17.7",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.2,
    "95% CI (%)": "0.0 - 4.8",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.5,
    "95% CI (%)": "0.0 - 11.2",
    "Sample Size": 122,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "2.6 - 6.0",
    "Sample Size": 687,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "3.4 - 13.0",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.7,
    "95% CI (%)": "1.0 - 10.5",
    "Sample Size": 164,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.1",
    "Sample Size": 118,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.4 - 5.4",
    "Sample Size": 586,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "3.1 - 7.3",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.7,
    "95% CI (%)": "3.1 - 8.4",
    "Sample Size": 381,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "0.0 - 8.4",
    "Sample Size": 123,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.3,
    "95% CI (%)": "3.9 - 8.8",
    "Sample Size": 560,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "2.5 - 6.1",
    "Sample Size": 671,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 3.7",
    "Sample Size": 260,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "3.1 - 7.3",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "1.6 - 10.7",
    "Sample Size": 131,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 756,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.4 - 7.0",
    "Sample Size": 358,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5,
    "95% CI (%)": "2.2 - 7.9",
    "Sample Size": 326,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "1.4 - 7.3",
    "Sample Size": 191,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.7,
    "95% CI (%)": "2.9 - 6.6",
    "Sample Size": 708,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.5,
    "95% CI (%)": "1.7 - 5.3",
    "Sample Size": 557,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.3,
    "95% CI (%)": "0.0 - 3.2",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "4.0 - 8.7",
    "Sample Size": 511,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.3,
    "95% CI (%)": "3.9 - 8.8",
    "Sample Size": 560,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.7,
    "95% CI (%)": "3.1 - 8.4",
    "Sample Size": 381,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 8.2,
    "95% CI (%)": "3.4 - 13.0",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.7 - 6.3",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "3.1 - 7.3",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "1.0 - 3.5",
    "Sample Size": 611,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "0.0 - 8.4",
    "Sample Size": 123,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.4",
    "Sample Size": 751,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.3,
    "95% CI (%)": "0.0 - 3.2",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "4.0 - 8.7",
    "Sample Size": 511,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.4,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 764,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.4 - 2.6",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.3,
    "95% CI (%)": "2.5 - 6.1",
    "Sample Size": 671,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 19.1,
    "95% CI (%)": "10.1 - 28.1",
    "Sample Size": 126,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.4 - 2.6",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "0.5 - 11.5",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.2 - 4.8",
    "Sample Size": 403,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.6,
    "95% CI (%)": "0.0 - 1.4",
    "Sample Size": 289,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.5,
    "95% CI (%)": "2.8 - 6.2",
    "Sample Size": 758,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "1.8 - 10.5",
    "Sample Size": 294,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "2.8 - 6.1",
    "Sample Size": 774,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "0.0 - 17.4",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1,
    "95% CI (%)": "0.0 - 3.0",
    "Sample Size": 39,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "2.9 - 6.3",
    "Sample Size": 747,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.2,
    "95% CI (%)": "1.8 - 10.5",
    "Sample Size": 294,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.2,
    "95% CI (%)": "1.8 - 6.6",
    "Sample Size": 416,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 7.8,
    "95% CI (%)": "3.9 - 11.7",
    "Sample Size": 213,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant, trying to get pregnant, or breastfeeding",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 3.3",
    "Sample Size": 107,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 2.3,
    "95% CI (%)": "1.0 - 3.5",
    "Sample Size": 611,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 6.3,
    "95% CI (%)": "3.9 - 8.8",
    "Sample Size": 560,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "3.1 - 7.3",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "2.3 - 5.5",
    "Sample Size": 651,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 0.7,
    "95% CI (%)": "0.0 - 1.8",
    "Sample Size": 207,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "0.0 - 8.4",
    "Sample Size": 123,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 1.3,
    "95% CI (%)": "0.0 - 3.2",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 1 - September 28",
    "Year": 2024,
    "Estimate (%)": 4.8,
    "95% CI (%)": "3.0 - 6.6",
    "Sample Size": 715,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.5,
    "95% CI (%)": "21.0 - 30.0",
    "Sample Size": 564,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2,
    "95% CI (%)": "0.0 - 4.3",
    "Sample Size": 275,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "8.6 - 14.1",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.2,
    "95% CI (%)": "23.0 - 37.4",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.1,
    "95% CI (%)": "2.4 - 7.8",
    "Sample Size": 372,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.1,
    "95% CI (%)": "17.4 - 26.9",
    "Sample Size": 425,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 23.9,
    "95% CI (%)": "19.9 - 27.9",
    "Sample Size": 673,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "10.5 - 17.7",
    "Sample Size": 506,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 21.8,
    "95% CI (%)": "14.8 - 28.7",
    "Sample Size": 203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.5 - 2.7",
    "Sample Size": 308,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 26.2,
    "95% CI (%)": "21.8 - 30.6",
    "Sample Size": 641,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.6,
    "95% CI (%)": "11.3 - 23.9",
    "Sample Size": 200,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "2.4 - 11.0",
    "Sample Size": 125,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "0.8 - 12.2",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "9.8 - 15.1",
    "Sample Size": 667,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.2,
    "95% CI (%)": "18.2 - 32.1",
    "Sample Size": 274,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "10.4 - 17.9",
    "Sample Size": 412,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "0.4 - 11.6",
    "Sample Size": 60,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "6.8 - 28.3",
    "Sample Size": 68,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "13.1 - 19.0",
    "Sample Size": 827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.3,
    "95% CI (%)": "12.5 - 18.2",
    "Sample Size": 867,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.9,
    "95% CI (%)": "8.8 - 29.0",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.8,
    "95% CI (%)": "9.6 - 20.1",
    "Sample Size": 263,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.9,
    "95% CI (%)": "4.7 - 41.1",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 12.0",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "8.8 - 19.4",
    "Sample Size": 218,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "3.6 - 12.2",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "16.0 - 23.7",
    "Sample Size": 649,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "0.0 - 13.3",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.5 - 19.2",
    "Sample Size": 919,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.9,
    "95% CI (%)": "14.3 - 23.4",
    "Sample Size": 417,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.2 - 21.0",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "14.7 - 20.9",
    "Sample Size": 872,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.1,
    "95% CI (%)": "4.1 - 16.2",
    "Sample Size": 108,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17,
    "95% CI (%)": "13.9 - 20.1",
    "Sample Size": 809,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 50.7,
    "95% CI (%)": "40.5 - 61.0",
    "Sample Size": 179,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.6 - 4.5",
    "Sample Size": 607,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.5 - 19.3",
    "Sample Size": 916,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.7,
    "95% CI (%)": "11.6 - 21.8",
    "Sample Size": 344,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 48,
    "95% CI (%)": "40.9 - 55.1",
    "Sample Size": 348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "0.0 - 13.5",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.0 - 1.7",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "13.6 - 19.3",
    "Sample Size": 920,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.5,
    "95% CI (%)": "16.8 - 34.3",
    "Sample Size": 178,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.8,
    "95% CI (%)": "0.0 - 14.2",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.2,
    "95% CI (%)": "13.3 - 19.0",
    "Sample Size": 908,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "13.2 - 18.9",
    "Sample Size": 930,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.6,
    "95% CI (%)": "24.6 - 36.5",
    "Sample Size": 399,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "3.6 - 9.2",
    "Sample Size": 305,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.2,
    "95% CI (%)": "13.4 - 19.0",
    "Sample Size": 921,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "0.0 - 17.5",
    "Sample Size": 30,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.4,
    "95% CI (%)": "12.7 - 18.1",
    "Sample Size": 934,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "13.3 - 19.0",
    "Sample Size": 925,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "13.2 - 18.8",
    "Sample Size": 927,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "1.3 - 22.0",
    "Sample Size": 55,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 12.0",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "3.6 - 12.2",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.9,
    "95% CI (%)": "13.9 - 19.9",
    "Sample Size": 856,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "8.0 - 14.4",
    "Sample Size": 531,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "16.0 - 23.7",
    "Sample Size": 649,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.9,
    "95% CI (%)": "6.3 - 27.5",
    "Sample Size": 63,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.6,
    "95% CI (%)": "13.1 - 26.2",
    "Sample Size": 254,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.7,
    "95% CI (%)": "13.0 - 18.4",
    "Sample Size": 958,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "6.8 - 20.0",
    "Sample Size": 153,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.9 - 20.3",
    "Sample Size": 738,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.4,
    "95% CI (%)": "0.0 - 8.8",
    "Sample Size": 41,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 27.3,
    "95% CI (%)": "12.0 - 42.5",
    "Sample Size": 53,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 4.4",
    "Sample Size": 51,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 32.6,
    "95% CI (%)": "25.7 - 39.5",
    "Sample Size": 314,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.5,
    "95% CI (%)": "3.3 - 11.6",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.8,
    "95% CI (%)": "23.3 - 30.3",
    "Sample Size": 948,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "1.3 - 31.5",
    "Sample Size": 34,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.7,
    "95% CI (%)": "24.2 - 31.3",
    "Sample Size": 948,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.4,
    "95% CI (%)": "0.0 - 17.1",
    "Sample Size": 41,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.8,
    "95% CI (%)": "24.2 - 31.4",
    "Sample Size": 939,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.2,
    "95% CI (%)": "23.7 - 30.7",
    "Sample Size": 954,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.7,
    "95% CI (%)": "24.1 - 31.3",
    "Sample Size": 938,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.4,
    "95% CI (%)": "23.9 - 31.0",
    "Sample Size": 944,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 51.9,
    "95% CI (%)": "46.1 - 57.7",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 67.4,
    "95% CI (%)": "56.5 - 78.3",
    "Sample Size": 167,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "1.6 - 5.6",
    "Sample Size": 441,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "22.4 - 34.6",
    "Sample Size": 349,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 24.7,
    "95% CI (%)": "17.3 - 32.1",
    "Sample Size": 198,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.1,
    "95% CI (%)": "13.4 - 26.9",
    "Sample Size": 168,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 51.5,
    "95% CI (%)": "43.8 - 59.2",
    "Sample Size": 302,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.1,
    "95% CI (%)": "5.9 - 32.2",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 36.8,
    "95% CI (%)": "19.3 - 54.3",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.2,
    "95% CI (%)": "0.6 - 19.7",
    "Sample Size": 43,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15,
    "95% CI (%)": "1.3 - 28.8",
    "Sample Size": 34,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 23.4,
    "95% CI (%)": "17.3 - 29.5",
    "Sample Size": 299,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.2,
    "95% CI (%)": "22.8 - 29.6",
    "Sample Size": 989,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 46.6,
    "95% CI (%)": "39.8 - 53.4",
    "Sample Size": 386,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.4,
    "95% CI (%)": "22.9 - 30.0",
    "Sample Size": 930,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 17.6,
    "95% CI (%)": "12.8 - 22.4",
    "Sample Size": 304,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 23.2,
    "95% CI (%)": "9.4 - 37.0",
    "Sample Size": 59,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.9,
    "95% CI (%)": "24.9 - 32.9",
    "Sample Size": 765,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15.3,
    "95% CI (%)": "9.0 - 21.7",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 17.3,
    "95% CI (%)": "8.8 - 25.7",
    "Sample Size": 106,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.1,
    "95% CI (%)": "23.4 - 30.9",
    "Sample Size": 833,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "0.0 - 9.9",
    "Sample Size": 30,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "0.0 - 11.4",
    "Sample Size": 49,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 29.9,
    "95% CI (%)": "24.5 - 35.3",
    "Sample Size": 438,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "24.8 - 32.2",
    "Sample Size": 904,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.2,
    "95% CI (%)": "23.7 - 30.8",
    "Sample Size": 956,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 23.4,
    "95% CI (%)": "7.5 - 39.2",
    "Sample Size": 40,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 21.9,
    "95% CI (%)": "15.1 - 28.7",
    "Sample Size": 231,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.4,
    "95% CI (%)": "20.7 - 34.1",
    "Sample Size": 247,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.9,
    "95% CI (%)": "2.7 - 25.2",
    "Sample Size": 57,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.4,
    "95% CI (%)": "8.9 - 31.9",
    "Sample Size": 73,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 30.4,
    "95% CI (%)": "26.0 - 34.8",
    "Sample Size": 668,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.5,
    "95% CI (%)": "16.0 - 24.9",
    "Sample Size": 449,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.5,
    "95% CI (%)": "12.1 - 26.8",
    "Sample Size": 141,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 25.9,
    "95% CI (%)": "3.4 - 48.4",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 25.4,
    "95% CI (%)": "13.9 - 36.8",
    "Sample Size": 90,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 31.5,
    "95% CI (%)": "26.4 - 36.5",
    "Sample Size": 540,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.5,
    "95% CI (%)": "16.9 - 24.1",
    "Sample Size": 682,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 33.7,
    "95% CI (%)": "16.6 - 50.9",
    "Sample Size": 58,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 25.9,
    "95% CI (%)": "22.3 - 29.6",
    "Sample Size": 850,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 41.4,
    "95% CI (%)": "33.8 - 49.0",
    "Sample Size": 291,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.8,
    "95% CI (%)": "14.9 - 38.7",
    "Sample Size": 66,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.3,
    "95% CI (%)": "1.3 - 5.2",
    "Sample Size": 315,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 24.5,
    "95% CI (%)": "16.5 - 32.6",
    "Sample Size": 144,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "9.6 - 47.4",
    "Sample Size": 38,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.1,
    "95% CI (%)": "22.6 - 29.7",
    "Sample Size": 894,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 53,
    "95% CI (%)": "43.4 - 62.6",
    "Sample Size": 198,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "11.1 - 22.0",
    "Sample Size": 192,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 22.6,
    "95% CI (%)": "18.2 - 27.1",
    "Sample Size": 534,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 41.5,
    "95% CI (%)": "36.5 - 46.5",
    "Sample Size": 668,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 1.3,
    "95% CI (%)": "0.2 - 2.4",
    "Sample Size": 304,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15,
    "95% CI (%)": "11.9 - 18.1",
    "Sample Size": 653,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.4 - 20.7",
    "Sample Size": 579,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 39,
    "95% CI (%)": "32.9 - 45.1",
    "Sample Size": 407,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.4,
    "95% CI (%)": "4.5 - 10.4",
    "Sample Size": 414,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 44.4,
    "95% CI (%)": "38.8 - 50.0",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 56.7,
    "95% CI (%)": "49.4 - 64.1",
    "Sample Size": 315,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 39.2,
    "95% CI (%)": "34.4 - 44.0",
    "Sample Size": 670,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 30.4,
    "95% CI (%)": "26.0 - 34.8",
    "Sample Size": 668,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.3,
    "95% CI (%)": "24.6 - 32.1",
    "Sample Size": 877,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 23.9,
    "95% CI (%)": "11.3 - 36.5",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.5,
    "95% CI (%)": "12.1 - 26.8",
    "Sample Size": 141,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.9,
    "95% CI (%)": "2.7 - 25.2",
    "Sample Size": 57,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 24.8,
    "95% CI (%)": "10.7 - 38.9",
    "Sample Size": 56,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "0.0 - 10.3",
    "Sample Size": 41,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.2,
    "95% CI (%)": "23.6 - 30.7",
    "Sample Size": 951,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.8,
    "95% CI (%)": "23.3 - 30.3",
    "Sample Size": 948,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "1.3 - 31.5",
    "Sample Size": 34,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 2.9,
    "95% CI (%)": "0.0 - 6.9",
    "Sample Size": 38,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "0.0 - 16.3",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.7,
    "95% CI (%)": "24.2 - 31.3",
    "Sample Size": 948,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.4,
    "95% CI (%)": "0.0 - 17.1",
    "Sample Size": 41,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.4,
    "95% CI (%)": "23.9 - 31.0",
    "Sample Size": 944,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.8,
    "95% CI (%)": "24.2 - 31.4",
    "Sample Size": 939,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.2,
    "95% CI (%)": "23.7 - 30.7",
    "Sample Size": 954,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.7,
    "95% CI (%)": "24.1 - 31.3",
    "Sample Size": 938,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.6,
    "95% CI (%)": "1.6 - 5.6",
    "Sample Size": 441,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 51.9,
    "95% CI (%)": "46.1 - 57.7",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 67.4,
    "95% CI (%)": "56.5 - 78.3",
    "Sample Size": 167,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "22.4 - 34.6",
    "Sample Size": 349,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 24.7,
    "95% CI (%)": "17.3 - 32.1",
    "Sample Size": 198,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.1,
    "95% CI (%)": "13.4 - 26.9",
    "Sample Size": 168,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 51.5,
    "95% CI (%)": "43.8 - 59.2",
    "Sample Size": 302,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.1,
    "95% CI (%)": "5.9 - 32.2",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 10.2,
    "95% CI (%)": "0.6 - 19.7",
    "Sample Size": 43,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 36.8,
    "95% CI (%)": "19.3 - 54.3",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15,
    "95% CI (%)": "1.3 - 28.8",
    "Sample Size": 34,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.2,
    "95% CI (%)": "22.8 - 29.6",
    "Sample Size": 989,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 23.4,
    "95% CI (%)": "17.3 - 29.5",
    "Sample Size": 299,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 17.6,
    "95% CI (%)": "12.8 - 22.4",
    "Sample Size": 304,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 23.2,
    "95% CI (%)": "9.4 - 37.0",
    "Sample Size": 59,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 46.6,
    "95% CI (%)": "39.8 - 53.4",
    "Sample Size": 386,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.4,
    "95% CI (%)": "22.9 - 30.0",
    "Sample Size": 930,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.9,
    "95% CI (%)": "24.9 - 32.9",
    "Sample Size": 765,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15.3,
    "95% CI (%)": "9.0 - 21.7",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 17.3,
    "95% CI (%)": "8.8 - 25.7",
    "Sample Size": 106,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.1,
    "95% CI (%)": "23.4 - 30.9",
    "Sample Size": 833,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "0.0 - 9.9",
    "Sample Size": 30,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.2,
    "95% CI (%)": "23.7 - 30.8",
    "Sample Size": 956,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 29.9,
    "95% CI (%)": "24.5 - 35.3",
    "Sample Size": 438,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "24.8 - 32.2",
    "Sample Size": 904,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 5.2,
    "95% CI (%)": "0.0 - 11.4",
    "Sample Size": 49,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 30.4,
    "95% CI (%)": "26.0 - 34.8",
    "Sample Size": 668,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 23.4,
    "95% CI (%)": "7.5 - 39.2",
    "Sample Size": 40,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.9,
    "95% CI (%)": "2.7 - 25.2",
    "Sample Size": 57,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 25.9,
    "95% CI (%)": "3.4 - 48.4",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.4,
    "95% CI (%)": "20.7 - 34.1",
    "Sample Size": 247,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.5,
    "95% CI (%)": "16.0 - 24.9",
    "Sample Size": 449,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.5,
    "95% CI (%)": "12.1 - 26.8",
    "Sample Size": 141,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.4,
    "95% CI (%)": "8.9 - 31.9",
    "Sample Size": 73,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 21.9,
    "95% CI (%)": "15.1 - 28.7",
    "Sample Size": 231,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 41.4,
    "95% CI (%)": "33.8 - 49.0",
    "Sample Size": 291,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 33.7,
    "95% CI (%)": "16.6 - 50.9",
    "Sample Size": 58,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 25.9,
    "95% CI (%)": "22.3 - 29.6",
    "Sample Size": 850,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 31.5,
    "95% CI (%)": "26.4 - 36.5",
    "Sample Size": 540,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 25.4,
    "95% CI (%)": "13.9 - 36.8",
    "Sample Size": 90,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 20.5,
    "95% CI (%)": "16.9 - 24.1",
    "Sample Size": 682,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.8,
    "95% CI (%)": "14.9 - 38.7",
    "Sample Size": 66,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "11.1 - 22.0",
    "Sample Size": 192,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 22.6,
    "95% CI (%)": "18.2 - 27.1",
    "Sample Size": 534,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 3.3,
    "95% CI (%)": "1.3 - 5.2",
    "Sample Size": 315,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 41.5,
    "95% CI (%)": "36.5 - 46.5",
    "Sample Size": 668,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 53,
    "95% CI (%)": "43.4 - 62.6",
    "Sample Size": 198,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 24.5,
    "95% CI (%)": "16.5 - 32.6",
    "Sample Size": 144,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 26.1,
    "95% CI (%)": "22.6 - 29.7",
    "Sample Size": 894,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.5,
    "95% CI (%)": "9.6 - 47.4",
    "Sample Size": 38,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.4,
    "95% CI (%)": "4.5 - 10.4",
    "Sample Size": 414,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 39,
    "95% CI (%)": "32.9 - 45.1",
    "Sample Size": 407,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 39.2,
    "95% CI (%)": "34.4 - 44.0",
    "Sample Size": 670,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 15,
    "95% CI (%)": "11.9 - 18.1",
    "Sample Size": 653,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.4 - 20.7",
    "Sample Size": 579,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 44.4,
    "95% CI (%)": "38.8 - 50.0",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 1.3,
    "95% CI (%)": "0.2 - 2.4",
    "Sample Size": 304,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 56.7,
    "95% CI (%)": "49.4 - 64.1",
    "Sample Size": 315,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 30.4,
    "95% CI (%)": "26.0 - 34.8",
    "Sample Size": 668,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 28.3,
    "95% CI (%)": "24.6 - 32.1",
    "Sample Size": 877,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 13.9,
    "95% CI (%)": "2.7 - 25.2",
    "Sample Size": 57,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 23.9,
    "95% CI (%)": "11.3 - 36.5",
    "Sample Size": 78,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 24.8,
    "95% CI (%)": "10.7 - 38.9",
    "Sample Size": 56,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 19.5,
    "95% CI (%)": "12.1 - 26.8",
    "Sample Size": 141,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 4.6,
    "95% CI (%)": "0.0 - 10.3",
    "Sample Size": 41,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 27.2,
    "95% CI (%)": "23.6 - 30.7",
    "Sample Size": 951,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 7.3,
    "95% CI (%)": "0.0 - 16.3",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 1 - December 28",
    "Year": 2024,
    "Estimate (%)": 2.9,
    "95% CI (%)": "0.0 - 6.9",
    "Sample Size": 38,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2,
    "95% CI (%)": "0.0 - 4.3",
    "Sample Size": 275,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "8.6 - 14.1",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.1,
    "95% CI (%)": "2.4 - 7.8",
    "Sample Size": 372,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.5,
    "95% CI (%)": "21.0 - 30.0",
    "Sample Size": 564,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "8.0 - 14.4",
    "Sample Size": 531,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 23.9,
    "95% CI (%)": "19.9 - 27.9",
    "Sample Size": 673,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.2,
    "95% CI (%)": "23.0 - 37.4",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.1,
    "95% CI (%)": "17.4 - 26.9",
    "Sample Size": 425,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "2.4 - 11.0",
    "Sample Size": 125,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 21.8,
    "95% CI (%)": "14.8 - 28.7",
    "Sample Size": 203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.5 - 2.7",
    "Sample Size": 308,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 26.2,
    "95% CI (%)": "21.8 - 30.6",
    "Sample Size": 641,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.6,
    "95% CI (%)": "11.3 - 23.9",
    "Sample Size": 200,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "10.5 - 17.7",
    "Sample Size": 506,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "0.8 - 12.2",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.2,
    "95% CI (%)": "18.2 - 32.1",
    "Sample Size": 274,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "6.8 - 28.3",
    "Sample Size": 68,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.3,
    "95% CI (%)": "12.5 - 18.2",
    "Sample Size": 867,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.9,
    "95% CI (%)": "8.8 - 29.0",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 12.0",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "10.4 - 17.9",
    "Sample Size": 412,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "9.8 - 15.1",
    "Sample Size": 667,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "13.1 - 19.0",
    "Sample Size": 827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "8.8 - 19.4",
    "Sample Size": 218,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "16.0 - 23.7",
    "Sample Size": 649,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "0.4 - 11.6",
    "Sample Size": 60,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "3.6 - 12.2",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.9,
    "95% CI (%)": "4.7 - 41.1",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.8,
    "95% CI (%)": "9.6 - 20.1",
    "Sample Size": 263,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.2 - 21.0",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "14.7 - 20.9",
    "Sample Size": 872,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.9,
    "95% CI (%)": "14.3 - 23.4",
    "Sample Size": 417,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17,
    "95% CI (%)": "13.9 - 20.1",
    "Sample Size": 809,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "0.0 - 13.3",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.5 - 19.2",
    "Sample Size": 919,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.1,
    "95% CI (%)": "4.1 - 16.2",
    "Sample Size": 108,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.7,
    "95% CI (%)": "11.6 - 21.8",
    "Sample Size": 344,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 50.7,
    "95% CI (%)": "40.5 - 61.0",
    "Sample Size": 179,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "13.6 - 19.3",
    "Sample Size": 920,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 48,
    "95% CI (%)": "40.9 - 55.1",
    "Sample Size": 348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.6 - 4.5",
    "Sample Size": 607,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "0.0 - 13.5",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.0 - 1.7",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.5 - 19.3",
    "Sample Size": 916,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.5,
    "95% CI (%)": "16.8 - 34.3",
    "Sample Size": 178,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.8,
    "95% CI (%)": "0.0 - 14.2",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.2,
    "95% CI (%)": "13.3 - 19.0",
    "Sample Size": 908,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "3.6 - 9.2",
    "Sample Size": 305,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.6,
    "95% CI (%)": "24.6 - 36.5",
    "Sample Size": 399,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "13.2 - 18.9",
    "Sample Size": 930,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "0.0 - 17.5",
    "Sample Size": 30,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.4,
    "95% CI (%)": "12.7 - 18.1",
    "Sample Size": 934,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.2,
    "95% CI (%)": "13.4 - 19.0",
    "Sample Size": 921,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "13.2 - 18.8",
    "Sample Size": 927,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "13.3 - 19.0",
    "Sample Size": 925,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "1.3 - 22.0",
    "Sample Size": 55,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "3.6 - 12.2",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 12.0",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.9,
    "95% CI (%)": "13.9 - 19.9",
    "Sample Size": 856,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "16.0 - 23.7",
    "Sample Size": 649,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.9,
    "95% CI (%)": "6.3 - 27.5",
    "Sample Size": 63,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.6,
    "95% CI (%)": "13.1 - 26.2",
    "Sample Size": 254,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.7,
    "95% CI (%)": "13.0 - 18.4",
    "Sample Size": 958,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "6.8 - 20.0",
    "Sample Size": 153,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.9 - 20.3",
    "Sample Size": 738,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.4,
    "95% CI (%)": "0.0 - 8.8",
    "Sample Size": 41,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 4.4",
    "Sample Size": 51,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 27.3,
    "95% CI (%)": "12.0 - 42.5",
    "Sample Size": 53,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 32.6,
    "95% CI (%)": "25.7 - 39.5",
    "Sample Size": 314,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.5,
    "95% CI (%)": "3.3 - 11.6",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.5,
    "95% CI (%)": "21.0 - 30.0",
    "Sample Size": 564,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 2,
    "95% CI (%)": "0.0 - 4.3",
    "Sample Size": 275,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.4,
    "95% CI (%)": "8.6 - 14.1",
    "Sample Size": 684,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.2,
    "95% CI (%)": "23.0 - 37.4",
    "Sample Size": 264,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.1,
    "95% CI (%)": "2.4 - 7.8",
    "Sample Size": 372,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.1,
    "95% CI (%)": "17.4 - 26.9",
    "Sample Size": 425,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 23.9,
    "95% CI (%)": "19.9 - 27.9",
    "Sample Size": 673,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "10.5 - 17.7",
    "Sample Size": 506,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 21.8,
    "95% CI (%)": "14.8 - 28.7",
    "Sample Size": 203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.5 - 2.7",
    "Sample Size": 308,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 26.2,
    "95% CI (%)": "21.8 - 30.6",
    "Sample Size": 641,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.6,
    "95% CI (%)": "11.3 - 23.9",
    "Sample Size": 200,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.7,
    "95% CI (%)": "2.4 - 11.0",
    "Sample Size": 125,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.5,
    "95% CI (%)": "0.8 - 12.2",
    "Sample Size": 52,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 12.4,
    "95% CI (%)": "9.8 - 15.1",
    "Sample Size": 667,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.2,
    "95% CI (%)": "18.2 - 32.1",
    "Sample Size": 274,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "10.4 - 17.9",
    "Sample Size": 412,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6,
    "95% CI (%)": "0.4 - 11.6",
    "Sample Size": 60,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "6.8 - 28.3",
    "Sample Size": 68,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "13.1 - 19.0",
    "Sample Size": 827,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.3,
    "95% CI (%)": "12.5 - 18.2",
    "Sample Size": 867,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.9,
    "95% CI (%)": "8.8 - 29.0",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.8,
    "95% CI (%)": "9.6 - 20.1",
    "Sample Size": 263,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 22.9,
    "95% CI (%)": "4.7 - 41.1",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 12.0",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 14.1,
    "95% CI (%)": "8.8 - 19.4",
    "Sample Size": 218,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "3.6 - 12.2",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "16.0 - 23.7",
    "Sample Size": 649,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 4.4,
    "95% CI (%)": "0.0 - 13.3",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.5 - 19.2",
    "Sample Size": 919,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 18.9,
    "95% CI (%)": "14.3 - 23.4",
    "Sample Size": 417,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.2 - 21.0",
    "Sample Size": 546,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "14.7 - 20.9",
    "Sample Size": 872,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 10.1,
    "95% CI (%)": "4.1 - 16.2",
    "Sample Size": 108,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17,
    "95% CI (%)": "13.9 - 20.1",
    "Sample Size": 809,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 50.7,
    "95% CI (%)": "40.5 - 61.0",
    "Sample Size": 179,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3,
    "95% CI (%)": "1.6 - 4.5",
    "Sample Size": 607,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "13.5 - 19.3",
    "Sample Size": 916,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.7,
    "95% CI (%)": "11.6 - 21.8",
    "Sample Size": 344,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 48,
    "95% CI (%)": "40.9 - 55.1",
    "Sample Size": 348,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.9,
    "95% CI (%)": "0.0 - 13.5",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 0.5,
    "95% CI (%)": "0.0 - 1.7",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.5,
    "95% CI (%)": "13.6 - 19.3",
    "Sample Size": 920,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 25.5,
    "95% CI (%)": "16.8 - 34.3",
    "Sample Size": 178,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.8,
    "95% CI (%)": "0.0 - 14.2",
    "Sample Size": 50,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.2,
    "95% CI (%)": "13.3 - 19.0",
    "Sample Size": 908,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "13.2 - 18.9",
    "Sample Size": 930,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 30.6,
    "95% CI (%)": "24.6 - 36.5",
    "Sample Size": 399,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "3.6 - 9.2",
    "Sample Size": 305,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.2,
    "95% CI (%)": "13.4 - 19.0",
    "Sample Size": 921,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "0.0 - 17.5",
    "Sample Size": 30,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.4,
    "95% CI (%)": "12.7 - 18.1",
    "Sample Size": 934,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.1,
    "95% CI (%)": "13.3 - 19.0",
    "Sample Size": 925,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16,
    "95% CI (%)": "13.2 - 18.8",
    "Sample Size": 927,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.6,
    "95% CI (%)": "1.3 - 22.0",
    "Sample Size": 55,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 12.0",
    "Sample Size": 70,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.9,
    "95% CI (%)": "3.6 - 12.2",
    "Sample Size": 145,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.9,
    "95% CI (%)": "13.9 - 19.9",
    "Sample Size": 856,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 11.2,
    "95% CI (%)": "8.0 - 14.4",
    "Sample Size": 531,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.9,
    "95% CI (%)": "16.0 - 23.7",
    "Sample Size": 649,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 16.9,
    "95% CI (%)": "6.3 - 27.5",
    "Sample Size": 63,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 19.6,
    "95% CI (%)": "13.1 - 26.2",
    "Sample Size": 254,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 15.7,
    "95% CI (%)": "13.0 - 18.4",
    "Sample Size": 958,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "6.8 - 20.0",
    "Sample Size": 153,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 17.1,
    "95% CI (%)": "13.9 - 20.3",
    "Sample Size": 738,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 3.4,
    "95% CI (%)": "0.0 - 8.8",
    "Sample Size": 41,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 27.3,
    "95% CI (%)": "12.0 - 42.5",
    "Sample Size": 53,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.0 - 4.4",
    "Sample Size": 51,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 32.6,
    "95% CI (%)": "25.7 - 39.5",
    "Sample Size": 314,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "September 29 - October 26",
    "Year": 2024,
    "Estimate (%)": 7.5,
    "95% CI (%)": "3.3 - 11.6",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 32.3,
    "95% CI (%)": "19.1 - 45.5",
    "Sample Size": 97,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 21.6,
    "95% CI (%)": "12.8 - 30.4",
    "Sample Size": 96,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 55.6,
    "95% CI (%)": "44.3 - 66.8",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 28.9,
    "95% CI (%)": "23.8 - 34.0",
    "Sample Size": 517,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 32.8,
    "95% CI (%)": "21.7 - 44.0",
    "Sample Size": 143,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 15.6,
    "95% CI (%)": "9.9 - 21.4",
    "Sample Size": 180,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 51.8,
    "95% CI (%)": "41.7 - 61.9",
    "Sample Size": 194,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.4,
    "95% CI (%)": "24.2 - 34.7",
    "Sample Size": 488,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 31,
    "95% CI (%)": "24.9 - 37.0",
    "Sample Size": 381,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 31.5,
    "95% CI (%)": "25.8 - 37.2",
    "Sample Size": 437,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 23.5,
    "95% CI (%)": "11.7 - 35.3",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 10.9,
    "95% CI (%)": "1.5 - 20.2",
    "Sample Size": 54,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 31,
    "95% CI (%)": "25.6 - 36.5",
    "Sample Size": 476,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "24.6 - 35.1",
    "Sample Size": 500,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 35,
    "95% CI (%)": "28.4 - 41.6",
    "Sample Size": 350,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "22.4 - 37.4",
    "Sample Size": 250,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 24.8,
    "95% CI (%)": "14.0 - 35.6",
    "Sample Size": 105,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.5,
    "95% CI (%)": "0.7 - 34.3",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 24.4,
    "95% CI (%)": "12.1 - 36.8",
    "Sample Size": 77,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.9,
    "95% CI (%)": "2.9 - 34.9",
    "Sample Size": 38,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 35.1,
    "95% CI (%)": "23.8 - 46.3",
    "Sample Size": 124,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "11.0 - 48.9",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 30.1,
    "95% CI (%)": "24.5 - 35.6",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 23.9,
    "95% CI (%)": "17.0 - 30.8",
    "Sample Size": 243,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 42.3,
    "95% CI (%)": "31.5 - 53.2",
    "Sample Size": 143,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 33.5,
    "95% CI (%)": "26.1 - 40.9",
    "Sample Size": 274,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 24.8,
    "95% CI (%)": "19.0 - 30.5",
    "Sample Size": 367,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 36.1,
    "95% CI (%)": "20.4 - 51.7",
    "Sample Size": 66,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 5.1,
    "95% CI (%)": "0.7 - 9.5",
    "Sample Size": 161,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 32,
    "95% CI (%)": "20.0 - 43.9",
    "Sample Size": 105,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.9,
    "95% CI (%)": "9.2 - 26.5",
    "Sample Size": 95,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 43,
    "95% CI (%)": "35.9 - 50.0",
    "Sample Size": 355,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 27.9,
    "95% CI (%)": "22.6 - 33.3",
    "Sample Size": 451,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 27.6,
    "95% CI (%)": "20.9 - 34.3",
    "Sample Size": 287,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 38.6,
    "95% CI (%)": "25.3 - 51.9",
    "Sample Size": 98,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 44.2,
    "95% CI (%)": "36.6 - 51.8",
    "Sample Size": 304,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 45.7,
    "95% CI (%)": "36.4 - 55.0",
    "Sample Size": 203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 21.2,
    "95% CI (%)": "15.8 - 26.6",
    "Sample Size": 365,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 52.4,
    "95% CI (%)": "40.6 - 64.3",
    "Sample Size": 144,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 2,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 153,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 42.6,
    "95% CI (%)": "35.8 - 49.5",
    "Sample Size": 362,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.6,
    "95% CI (%)": "13.1 - 24.0",
    "Sample Size": 312,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.5,
    "95% CI (%)": "0.7 - 34.3",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11.2,
    "95% CI (%)": "5.2 - 17.2",
    "Sample Size": 195,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 30.5,
    "95% CI (%)": "25.0 - 35.9",
    "Sample Size": 468,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 8.6,
    "95% CI (%)": "1.5 - 15.7",
    "Sample Size": 34,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 35,
    "95% CI (%)": "28.4 - 41.6",
    "Sample Size": 350,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 24.4,
    "95% CI (%)": "12.1 - 36.8",
    "Sample Size": 77,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.5,
    "95% CI (%)": "24.3 - 34.7",
    "Sample Size": 503,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.1,
    "95% CI (%)": "23.9 - 34.2",
    "Sample Size": 503,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "24.6 - 35.1",
    "Sample Size": 499,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "24.7 - 35.1",
    "Sample Size": 499,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.1,
    "95% CI (%)": "23.9 - 34.2",
    "Sample Size": 505,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.7,
    "95% CI (%)": "24.5 - 34.9",
    "Sample Size": 504,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.4,
    "95% CI (%)": "24.2 - 34.6",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 54.4,
    "95% CI (%)": "46.6 - 62.2",
    "Sample Size": 296,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 4.3,
    "95% CI (%)": "0.4 - 8.2",
    "Sample Size": 220,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 79,
    "95% CI (%)": "67.0 - 91.1",
    "Sample Size": 84,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 33.5,
    "95% CI (%)": "23.3 - 43.7",
    "Sample Size": 183,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 32.3,
    "95% CI (%)": "19.1 - 45.5",
    "Sample Size": 97,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 21.6,
    "95% CI (%)": "12.8 - 30.4",
    "Sample Size": 96,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 55.6,
    "95% CI (%)": "44.3 - 66.8",
    "Sample Size": 157,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 32.8,
    "95% CI (%)": "21.7 - 44.0",
    "Sample Size": 143,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 28.9,
    "95% CI (%)": "23.8 - 34.0",
    "Sample Size": 517,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 15.6,
    "95% CI (%)": "9.9 - 21.4",
    "Sample Size": 180,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 51.8,
    "95% CI (%)": "41.7 - 61.9",
    "Sample Size": 194,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.4,
    "95% CI (%)": "24.2 - 34.7",
    "Sample Size": 488,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 23.5,
    "95% CI (%)": "11.7 - 35.3",
    "Sample Size": 89,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 31,
    "95% CI (%)": "24.9 - 37.0",
    "Sample Size": 381,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 10.9,
    "95% CI (%)": "1.5 - 20.2",
    "Sample Size": 54,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 31.5,
    "95% CI (%)": "25.8 - 37.2",
    "Sample Size": 437,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 31,
    "95% CI (%)": "25.6 - 36.5",
    "Sample Size": 476,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "24.6 - 35.1",
    "Sample Size": 500,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 35,
    "95% CI (%)": "28.4 - 41.6",
    "Sample Size": 350,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.9,
    "95% CI (%)": "2.9 - 34.9",
    "Sample Size": 38,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 35.1,
    "95% CI (%)": "23.8 - 46.3",
    "Sample Size": 124,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 24.8,
    "95% CI (%)": "14.0 - 35.6",
    "Sample Size": 105,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.5,
    "95% CI (%)": "0.7 - 34.3",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 24.4,
    "95% CI (%)": "12.1 - 36.8",
    "Sample Size": 77,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "22.4 - 37.4",
    "Sample Size": 250,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 30.1,
    "95% CI (%)": "24.5 - 35.6",
    "Sample Size": 448,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 24.8,
    "95% CI (%)": "19.0 - 30.5",
    "Sample Size": 367,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 33.5,
    "95% CI (%)": "26.1 - 40.9",
    "Sample Size": 274,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 23.9,
    "95% CI (%)": "17.0 - 30.8",
    "Sample Size": 243,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 36.1,
    "95% CI (%)": "20.4 - 51.7",
    "Sample Size": 66,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "11.0 - 48.9",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 42.3,
    "95% CI (%)": "31.5 - 53.2",
    "Sample Size": 143,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 5.1,
    "95% CI (%)": "0.7 - 9.5",
    "Sample Size": 161,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.9,
    "95% CI (%)": "9.2 - 26.5",
    "Sample Size": 95,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 27.9,
    "95% CI (%)": "22.6 - 33.3",
    "Sample Size": 451,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 32,
    "95% CI (%)": "20.0 - 43.9",
    "Sample Size": 105,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 27.6,
    "95% CI (%)": "20.9 - 34.3",
    "Sample Size": 287,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 38.6,
    "95% CI (%)": "25.3 - 51.9",
    "Sample Size": 98,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 43,
    "95% CI (%)": "35.9 - 50.0",
    "Sample Size": 355,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 21.2,
    "95% CI (%)": "15.8 - 26.6",
    "Sample Size": 365,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 52.4,
    "95% CI (%)": "40.6 - 64.3",
    "Sample Size": 144,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 44.2,
    "95% CI (%)": "36.6 - 51.8",
    "Sample Size": 304,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 18.6,
    "95% CI (%)": "13.1 - 24.0",
    "Sample Size": 312,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 2,
    "95% CI (%)": "0.0 - 3.9",
    "Sample Size": 153,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 42.6,
    "95% CI (%)": "35.8 - 49.5",
    "Sample Size": 362,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 45.7,
    "95% CI (%)": "36.4 - 55.0",
    "Sample Size": 203,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 30.5,
    "95% CI (%)": "25.0 - 35.9",
    "Sample Size": 468,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 17.5,
    "95% CI (%)": "0.7 - 34.3",
    "Sample Size": 37,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 11.2,
    "95% CI (%)": "5.2 - 17.2",
    "Sample Size": 195,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 8.6,
    "95% CI (%)": "1.5 - 15.7",
    "Sample Size": 34,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 35,
    "95% CI (%)": "28.4 - 41.6",
    "Sample Size": 350,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 24.4,
    "95% CI (%)": "12.1 - 36.8",
    "Sample Size": 77,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.5,
    "95% CI (%)": "24.3 - 34.7",
    "Sample Size": 503,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.1,
    "95% CI (%)": "23.9 - 34.2",
    "Sample Size": 503,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "24.6 - 35.1",
    "Sample Size": 499,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.9,
    "95% CI (%)": "24.7 - 35.1",
    "Sample Size": 499,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.7,
    "95% CI (%)": "24.5 - 34.9",
    "Sample Size": 504,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.1,
    "95% CI (%)": "23.9 - 34.2",
    "Sample Size": 505,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 29.4,
    "95% CI (%)": "24.2 - 34.6",
    "Sample Size": 507,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 54.4,
    "95% CI (%)": "46.6 - 62.2",
    "Sample Size": 296,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 4.3,
    "95% CI (%)": "0.4 - 8.2",
    "Sample Size": 220,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 79,
    "95% CI (%)": "67.0 - 91.1",
    "Sample Size": 84,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "December 29 - January 25",
    "Year": 2025,
    "Estimate (%)": 33.5,
    "95% CI (%)": "23.3 - 43.7",
    "Sample Size": 183,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.2,
    "95% CI (%)": "4.1 - 20.4",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 44.3,
    "95% CI (%)": "30.9 - 57.6",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.9,
    "95% CI (%)": "0.7 - 13.2",
    "Sample Size": 66,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "17.9 - 31.3",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17,
    "95% CI (%)": "12.0 - 22.0",
    "Sample Size": 265,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 52.7,
    "95% CI (%)": "47.2 - 58.3",
    "Sample Size": 488,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "0.8 - 11.9",
    "Sample Size": 77,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24,
    "95% CI (%)": "21.4 - 26.6",
    "Sample Size": 1469,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 20.9,
    "95% CI (%)": "16.0 - 25.9",
    "Sample Size": 380,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "10.0 - 16.8",
    "Sample Size": 469,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 48.8,
    "95% CI (%)": "43.8 - 53.9",
    "Sample Size": 620,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "8.2 - 24.6",
    "Sample Size": 83,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "21.9 - 27.3",
    "Sample Size": 1386,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.9,
    "95% CI (%)": "22.8 - 28.9",
    "Sample Size": 1126,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "6.3 - 15.8",
    "Sample Size": 156,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.9,
    "95% CI (%)": "12.3 - 23.5",
    "Sample Size": 246,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26,
    "95% CI (%)": "23.0 - 28.9",
    "Sample Size": 1253,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 11.6",
    "Sample Size": 79,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26.1,
    "95% CI (%)": "23.3 - 28.9",
    "Sample Size": 1354,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.1,
    "95% CI (%)": "22.4 - 27.8",
    "Sample Size": 1416,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 27.6,
    "95% CI (%)": "22.2 - 33.0",
    "Sample Size": 390,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26.4,
    "95% CI (%)": "22.3 - 30.5",
    "Sample Size": 651,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.3",
    "Sample Size": 49,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "12.1 - 22.9",
    "Sample Size": 208,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "4.5 - 15.4",
    "Sample Size": 116,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 20.5,
    "95% CI (%)": "15.5 - 25.6",
    "Sample Size": 330,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "3.6 - 18.9",
    "Sample Size": 98,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.2,
    "95% CI (%)": "0.1 - 18.3",
    "Sample Size": 35,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 29.1,
    "95% CI (%)": "25.7 - 32.6",
    "Sample Size": 1009,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.5,
    "95% CI (%)": "21.6 - 27.3",
    "Sample Size": 1251,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.7,
    "95% CI (%)": "12.9 - 36.4",
    "Sample Size": 83,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "8.1 - 41.2",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 21.2,
    "95% CI (%)": "17.7 - 24.7",
    "Sample Size": 691,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26.6,
    "95% CI (%)": "22.8 - 30.4",
    "Sample Size": 778,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 23.2,
    "95% CI (%)": "14.5 - 31.9",
    "Sample Size": 116,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.4,
    "95% CI (%)": "19.5 - 31.2",
    "Sample Size": 313,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 23.5,
    "95% CI (%)": "20.7 - 26.2",
    "Sample Size": 1312,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 19.7,
    "95% CI (%)": "16.8 - 22.5",
    "Sample Size": 1005,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.8,
    "95% CI (%)": "3.6 - 24.0",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.9,
    "95% CI (%)": "12.2 - 23.6",
    "Sample Size": 229,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 21,
    "95% CI (%)": "17.7 - 24.4",
    "Sample Size": 781,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 35.7,
    "95% CI (%)": "28.8 - 42.6",
    "Sample Size": 303,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 37,
    "95% CI (%)": "31.2 - 42.9",
    "Sample Size": 442,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 28.4,
    "95% CI (%)": "19.9 - 36.9",
    "Sample Size": 153,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "1.8 - 6.0",
    "Sample Size": 475,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 38.9,
    "95% CI (%)": "35.0 - 42.8",
    "Sample Size": 991,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15.2,
    "95% CI (%)": "12.7 - 17.7",
    "Sample Size": 1016,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 38.7,
    "95% CI (%)": "33.8 - 43.5",
    "Sample Size": 618,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15.2,
    "95% CI (%)": "12.5 - 17.9",
    "Sample Size": 844,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 49.6,
    "95% CI (%)": "43.3 - 55.9",
    "Sample Size": 432,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "7.2 - 28.3",
    "Sample Size": 97,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "12.1 - 22.9",
    "Sample Size": 208,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 29.1,
    "95% CI (%)": "25.7 - 32.6",
    "Sample Size": 1009,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 37.9,
    "95% CI (%)": "34.1 - 41.8",
    "Sample Size": 984,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "3.2 - 7.5",
    "Sample Size": 588,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 43.7,
    "95% CI (%)": "39.4 - 48.1",
    "Sample Size": 832,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "4.5 - 15.4",
    "Sample Size": 116,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.4,
    "95% CI (%)": "0.0 - 35.4",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.4 - 2.5",
    "Sample Size": 463,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "21.9 - 27.3",
    "Sample Size": 1427,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.5,
    "95% CI (%)": "0.5 - 18.5",
    "Sample Size": 34,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.9,
    "95% CI (%)": "23.1 - 28.8",
    "Sample Size": 1318,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.4,
    "95% CI (%)": "3.5 - 25.2",
    "Sample Size": 76,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "0.4 - 20.4",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.4,
    "95% CI (%)": "21.7 - 27.0",
    "Sample Size": 1430,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.5,
    "95% CI (%)": "21.9 - 27.2",
    "Sample Size": 1428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "3.9 - 31.6",
    "Sample Size": 51,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "21.9 - 27.3",
    "Sample Size": 1406,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.6,
    "95% CI (%)": "0.0 - 28.7",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "21.9 - 27.2",
    "Sample Size": 1428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.8,
    "95% CI (%)": "0.0 - 5.5",
    "Sample Size": 42,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.2,
    "95% CI (%)": "22.5 - 27.9",
    "Sample Size": 1409,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.3 - 5.8",
    "Sample Size": 726,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 51.9,
    "95% CI (%)": "47.0 - 56.7",
    "Sample Size": 741,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.1,
    "95% CI (%)": "22.4 - 27.9",
    "Sample Size": 1419,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 30.3,
    "95% CI (%)": "25.2 - 35.5",
    "Sample Size": 525,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Received at least one dose of the 2024-2025 COVID-19  vaccine",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 70,
    "95% CI (%)": "62.2 - 77.7",
    "Sample Size": 260,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 12.2,
    "95% CI (%)": "4.1 - 20.4",
    "Sample Size": 62,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 44.3,
    "95% CI (%)": "30.9 - 57.6",
    "Sample Size": 80,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.9,
    "95% CI (%)": "0.7 - 13.2",
    "Sample Size": 66,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "50-64 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "17.9 - 31.3",
    "Sample Size": 256,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17,
    "95% CI (%)": "12.0 - 22.0",
    "Sample Size": 265,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "65+ years, White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 52.7,
    "95% CI (%)": "47.2 - 58.3",
    "Sample Size": 488,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age by race/ethnicity",
    "Group Category": "18-49 years, Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 6.4,
    "95% CI (%)": "0.8 - 11.9",
    "Sample Size": 77,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "All adults 18+ years",
    "Group Category": "All adults 18+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24,
    "95% CI (%)": "21.4 - 26.6",
    "Sample Size": 1469,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "50-64 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 20.9,
    "95% CI (%)": "16.0 - 25.9",
    "Sample Size": 380,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "18-49 years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.4,
    "95% CI (%)": "10.0 - 16.8",
    "Sample Size": 469,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Urban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 16.4,
    "95% CI (%)": "8.2 - 24.6",
    "Sample Size": 83,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Age",
    "Group Category": "65+ years",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 48.8,
    "95% CI (%)": "43.8 - 53.9",
    "Sample Size": 620,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Metropolitan statistical area",
    "Group Category": "Suburban",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "21.9 - 27.3",
    "Sample Size": 1386,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "Moderate SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.9,
    "95% CI (%)": "22.8 - 28.9",
    "Sample Size": 1126,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Social Vulnerability Index (SVI) of county of residence",
    "Group Category": "High SVI",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.9,
    "95% CI (%)": "12.3 - 23.5",
    "Sample Size": 246,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Not born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11,
    "95% CI (%)": "6.3 - 15.8",
    "Sample Size": 156,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Born in the U.S.",
    "Group Category": "Born in the U.S.",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26,
    "95% CI (%)": "23.0 - 28.9",
    "Sample Size": 1253,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "English",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.1,
    "95% CI (%)": "22.4 - 27.8",
    "Sample Size": 1416,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Not insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "0.0 - 11.6",
    "Sample Size": 79,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Insurance status",
    "Group Category": "Insured",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26.1,
    "95% CI (%)": "23.3 - 28.9",
    "Sample Size": 1354,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Below poverty",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 11.3,
    "95% CI (%)": "3.6 - 18.9",
    "Sample Size": 98,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "12.1 - 22.9",
    "Sample Size": 208,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Unknown income",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 20.5,
    "95% CI (%)": "15.5 - 25.6",
    "Sample Size": 330,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Asian, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.2,
    "95% CI (%)": "0.1 - 18.3",
    "Sample Size": 35,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Language of interview",
    "Group Category": "Spanish",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.6,
    "95% CI (%)": "0.0 - 3.3",
    "Sample Size": 49,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income <$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 27.6,
    "95% CI (%)": "22.2 - 33.0",
    "Sample Size": 390,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Poverty status",
    "Group Category": "Above poverty, income >=$75k",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26.4,
    "95% CI (%)": "22.3 - 30.5",
    "Sample Size": 651,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 29.1,
    "95% CI (%)": "25.7 - 32.6",
    "Sample Size": 1009,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "4.5 - 15.4",
    "Sample Size": 116,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.7,
    "95% CI (%)": "12.9 - 36.4",
    "Sample Size": 83,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Female",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 26.6,
    "95% CI (%)": "22.8 - 30.4",
    "Sample Size": 778,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Gay/Lesbian/Bisexual/Other",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 23.2,
    "95% CI (%)": "14.5 - 31.9",
    "Sample Size": 116,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sex",
    "Group Category": "Male",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 21.2,
    "95% CI (%)": "17.7 - 24.7",
    "Sample Size": 691,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Sexual orientation",
    "Group Category": "Heterosexual/Straight",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.5,
    "95% CI (%)": "21.6 - 27.3",
    "Sample Size": 1251,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (7 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "8.1 - 41.2",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Worse than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.8,
    "95% CI (%)": "3.6 - 24.0",
    "Sample Size": 46,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Pregnancy status (females age 18-49 years)",
    "Group Category": "Not pregnant",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.9,
    "95% CI (%)": "12.2 - 23.6",
    "Sample Size": 229,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Don't know/refused",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.4,
    "95% CI (%)": "19.5 - 31.2",
    "Sample Size": 313,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Better than other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 35.7,
    "95% CI (%)": "28.8 - 42.6",
    "Sample Size": 303,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 37,
    "95% CI (%)": "31.2 - 42.9",
    "Sample Size": 442,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Self-perceived equity in seeking healthcare compared to other races/ethnicities",
    "Group Category": "Same as other races or ethnicities",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 21,
    "95% CI (%)": "17.7 - 24.4",
    "Sample Size": 781,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Health condition associated with higher risk for viral respiratory diseases",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 19.7,
    "95% CI (%)": "16.8 - 22.5",
    "Sample Size": 1005,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 23.5,
    "95% CI (%)": "20.7 - 26.2",
    "Sample Size": 1312,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Disability status (any)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 28.4,
    "95% CI (%)": "19.9 - 36.9",
    "Sample Size": 153,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "Very or moderately concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 38.7,
    "95% CI (%)": "33.8 - 43.5",
    "Sample Size": 618,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 38.9,
    "95% CI (%)": "35.0 - 42.8",
    "Sample Size": 991,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15.2,
    "95% CI (%)": "12.7 - 17.7",
    "Sample Size": 1016,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received any non-COVID-19 vaccine(s) in past two years",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 3.9,
    "95% CI (%)": "1.8 - 6.0",
    "Sample Size": 475,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Concern about getting COVID-19 disease",
    "Group Category": "A little or not at all concerned",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 15.2,
    "95% CI (%)": "12.5 - 17.9",
    "Sample Size": 844,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Healthcare provider recommended I get a COVID-19 vaccine",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 49.6,
    "95% CI (%)": "43.3 - 55.9",
    "Sample Size": 432,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Other or multiple races, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "7.2 - 28.3",
    "Sample Size": 97,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "A little or not at all important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.5,
    "95% CI (%)": "0.4 - 2.5",
    "Sample Size": 463,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence that COVID-19 vaccine is important",
    "Group Category": "Somewhat or very important to protect me from COVID-19",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 37.9,
    "95% CI (%)": "34.1 - 41.8",
    "Sample Size": 984,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.9,
    "95% CI (%)": "4.5 - 15.4",
    "Sample Size": 116,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Somewhat or not at all safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 5.4,
    "95% CI (%)": "3.2 - 7.5",
    "Sample Size": 588,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Confidence in COVID-19 vaccine safety",
    "Group Category": "Very or completely safe for me",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 43.7,
    "95% CI (%)": "39.4 - 48.1",
    "Sample Size": 832,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "White, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 29.1,
    "95% CI (%)": "25.7 - 32.6",
    "Sample Size": 1009,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Race/Ethnicity (4 level)",
    "Group Category": "Black, non-Hispanic",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.5,
    "95% CI (%)": "12.1 - 22.9",
    "Sample Size": 208,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.4,
    "95% CI (%)": "21.7 - 27.0",
    "Sample Size": 1430,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is a little difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 14.4,
    "95% CI (%)": "3.5 - 25.2",
    "Sample Size": 76,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is somewhat difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 9.5,
    "95% CI (%)": "0.5 - 18.5",
    "Sample Size": 34,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 10.4,
    "95% CI (%)": "0.4 - 20.4",
    "Sample Size": 32,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting COVID-19 vaccine",
    "Group Category": "Getting a COVID-19 vaccine is not at all difficult",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.9,
    "95% CI (%)": "23.1 - 28.8",
    "Sample Size": 1318,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty knowing where to get vaccinated",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.4,
    "95% CI (%)": "0.0 - 35.4",
    "Sample Size": 33,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty getting an appointment online",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "21.9 - 27.3",
    "Sample Size": 1427,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 17.8,
    "95% CI (%)": "3.9 - 31.6",
    "Sample Size": 51,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Vaccination sites not open at convenient times",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "21.9 - 27.3",
    "Sample Size": 1406,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 13.6,
    "95% CI (%)": "0.0 - 28.7",
    "Sample Size": 31,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Not sure whether eligible",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.6,
    "95% CI (%)": "21.9 - 27.2",
    "Sample Size": 1428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Reaction to previous dose of COVID-19 vaccine",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.2,
    "95% CI (%)": "22.5 - 27.9",
    "Sample Size": 1409,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Hard to get to vaccination site",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 24.5,
    "95% CI (%)": "21.9 - 27.2",
    "Sample Size": 1428,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 1.8,
    "95% CI (%)": "0.0 - 5.5",
    "Sample Size": 42,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 51.9,
    "95% CI (%)": "47.0 - 56.7",
    "Sample Size": 741,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received a flu vaccination since July 1, 2024",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 4,
    "95% CI (%)": "2.3 - 5.8",
    "Sample Size": 726,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Difficulty with cost (including payments, transportation, time off)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 25.1,
    "95% CI (%)": "22.4 - 27.9",
    "Sample Size": 1419,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "Yes",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 70,
    "95% CI (%)": "62.2 - 77.7",
    "Sample Size": 260,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  },
  {
    "Geography Type": "State",
    "Geography": "Delaware",
    "Group Name": "Received an RSV vaccination (ever)",
    "Group Category": "No",
    "Indicator Name": "Vaccination coverage and intent (among all adults 18+)",
    "Indicator Category": "Received a 2024-2025 COVID-19 dose",
    "Time Period": "October 27 - November 30",
    "Year": 2024,
    "Estimate (%)": 30.3,
    "95% CI (%)": "25.2 - 35.5",
    "Sample Size": 525,
    "Vaccine": "COVID-19",
    "Suppression Flag": 0
  }
]
